Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis

Aparna Vasanthakumar, Janet B. Lepore, Matthew H. Zegarek, Masha Kocherginsky, Mahi Singh, Elizabeth M. Davis, Petra A. Link, John Anastasi, Michelle M. Le Beau, Adam R. Karpf, Lucy A. Godley*

*Corresponding author for this work

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The drivers of abnormal DNA methylation in human cancers include widespread aberrant splicing of the DNMT3B gene, producing abnormal transcripts that encode truncated proteins that may act as dominant negative isoforms. To test whether reduced Dnmt3b dosage can alter tumorigenesis, we bred Dnmt3b+/- mice to Em-Myc mice, a mouse model susceptible to B-cell lymphomas. Em-Myc/Dnmt3b+/- mice showed a dramatic acceleration of lymphomagenesis, greater even than that observed in Em-Myc mice that express a truncated DNMT3B isoform found in human tumors, DNMT3B7. This finding indicates that Dnmt3b can act as a haploinsufficient tumor suppressor gene. Although reduction in both Dnmt3b dosage and expression of DNMT3B7 within the Em-Myc system had similar effects on tumorigenesis and DNA hypermethylation, different molecular mechanisms appear to underlie these changes. This study offers insight into how de novo DNA methyltransferases function as tumor suppressors and the sensitivity of Myc-induced lymphomas to DNA methylation.

Original languageEnglish (US)
Pages (from-to)2059-2063
Number of pages5
JournalBlood
Volume121
Issue number11
DOIs
StatePublished - Jan 1 2013

Fingerprint

Tumor Suppressor Genes
Tumors
Genes
Protein Isoforms
DNA Methylation
DNA
Methyltransferases
Carcinogenesis
Neoplasms
Cells
B-Cell Lymphoma
Lymphoma
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Vasanthakumar, A., Lepore, J. B., Zegarek, M. H., Kocherginsky, M., Singh, M., Davis, E. M., ... Godley, L. A. (2013). Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis. Blood, 121(11), 2059-2063. https://doi.org/10.1182/blood-2012-04-421065
Vasanthakumar, Aparna ; Lepore, Janet B. ; Zegarek, Matthew H. ; Kocherginsky, Masha ; Singh, Mahi ; Davis, Elizabeth M. ; Link, Petra A. ; Anastasi, John ; Le Beau, Michelle M. ; Karpf, Adam R. ; Godley, Lucy A. / Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis. In: Blood. 2013 ; Vol. 121, No. 11. pp. 2059-2063.
@article{d607643b08cf433ab978db2cba83e24d,
title = "Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis",
abstract = "The drivers of abnormal DNA methylation in human cancers include widespread aberrant splicing of the DNMT3B gene, producing abnormal transcripts that encode truncated proteins that may act as dominant negative isoforms. To test whether reduced Dnmt3b dosage can alter tumorigenesis, we bred Dnmt3b+/- mice to Em-Myc mice, a mouse model susceptible to B-cell lymphomas. Em-Myc/Dnmt3b+/- mice showed a dramatic acceleration of lymphomagenesis, greater even than that observed in Em-Myc mice that express a truncated DNMT3B isoform found in human tumors, DNMT3B7. This finding indicates that Dnmt3b can act as a haploinsufficient tumor suppressor gene. Although reduction in both Dnmt3b dosage and expression of DNMT3B7 within the Em-Myc system had similar effects on tumorigenesis and DNA hypermethylation, different molecular mechanisms appear to underlie these changes. This study offers insight into how de novo DNA methyltransferases function as tumor suppressors and the sensitivity of Myc-induced lymphomas to DNA methylation.",
author = "Aparna Vasanthakumar and Lepore, {Janet B.} and Zegarek, {Matthew H.} and Masha Kocherginsky and Mahi Singh and Davis, {Elizabeth M.} and Link, {Petra A.} and John Anastasi and {Le Beau}, {Michelle M.} and Karpf, {Adam R.} and Godley, {Lucy A.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1182/blood-2012-04-421065",
language = "English (US)",
volume = "121",
pages = "2059--2063",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "11",

}

Vasanthakumar, A, Lepore, JB, Zegarek, MH, Kocherginsky, M, Singh, M, Davis, EM, Link, PA, Anastasi, J, Le Beau, MM, Karpf, AR & Godley, LA 2013, 'Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis', Blood, vol. 121, no. 11, pp. 2059-2063. https://doi.org/10.1182/blood-2012-04-421065

Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis. / Vasanthakumar, Aparna; Lepore, Janet B.; Zegarek, Matthew H.; Kocherginsky, Masha; Singh, Mahi; Davis, Elizabeth M.; Link, Petra A.; Anastasi, John; Le Beau, Michelle M.; Karpf, Adam R.; Godley, Lucy A.

In: Blood, Vol. 121, No. 11, 01.01.2013, p. 2059-2063.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis

AU - Vasanthakumar, Aparna

AU - Lepore, Janet B.

AU - Zegarek, Matthew H.

AU - Kocherginsky, Masha

AU - Singh, Mahi

AU - Davis, Elizabeth M.

AU - Link, Petra A.

AU - Anastasi, John

AU - Le Beau, Michelle M.

AU - Karpf, Adam R.

AU - Godley, Lucy A.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - The drivers of abnormal DNA methylation in human cancers include widespread aberrant splicing of the DNMT3B gene, producing abnormal transcripts that encode truncated proteins that may act as dominant negative isoforms. To test whether reduced Dnmt3b dosage can alter tumorigenesis, we bred Dnmt3b+/- mice to Em-Myc mice, a mouse model susceptible to B-cell lymphomas. Em-Myc/Dnmt3b+/- mice showed a dramatic acceleration of lymphomagenesis, greater even than that observed in Em-Myc mice that express a truncated DNMT3B isoform found in human tumors, DNMT3B7. This finding indicates that Dnmt3b can act as a haploinsufficient tumor suppressor gene. Although reduction in both Dnmt3b dosage and expression of DNMT3B7 within the Em-Myc system had similar effects on tumorigenesis and DNA hypermethylation, different molecular mechanisms appear to underlie these changes. This study offers insight into how de novo DNA methyltransferases function as tumor suppressors and the sensitivity of Myc-induced lymphomas to DNA methylation.

AB - The drivers of abnormal DNA methylation in human cancers include widespread aberrant splicing of the DNMT3B gene, producing abnormal transcripts that encode truncated proteins that may act as dominant negative isoforms. To test whether reduced Dnmt3b dosage can alter tumorigenesis, we bred Dnmt3b+/- mice to Em-Myc mice, a mouse model susceptible to B-cell lymphomas. Em-Myc/Dnmt3b+/- mice showed a dramatic acceleration of lymphomagenesis, greater even than that observed in Em-Myc mice that express a truncated DNMT3B isoform found in human tumors, DNMT3B7. This finding indicates that Dnmt3b can act as a haploinsufficient tumor suppressor gene. Although reduction in both Dnmt3b dosage and expression of DNMT3B7 within the Em-Myc system had similar effects on tumorigenesis and DNA hypermethylation, different molecular mechanisms appear to underlie these changes. This study offers insight into how de novo DNA methyltransferases function as tumor suppressors and the sensitivity of Myc-induced lymphomas to DNA methylation.

UR - http://www.scopus.com/inward/record.url?scp=84877595762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877595762&partnerID=8YFLogxK

U2 - 10.1182/blood-2012-04-421065

DO - 10.1182/blood-2012-04-421065

M3 - Article

VL - 121

SP - 2059

EP - 2063

JO - Blood

JF - Blood

SN - 0006-4971

IS - 11

ER -

Vasanthakumar A, Lepore JB, Zegarek MH, Kocherginsky M, Singh M, Davis EM et al. Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis. Blood. 2013 Jan 1;121(11):2059-2063. https://doi.org/10.1182/blood-2012-04-421065